Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BlackThorn Therapeutics
Biotech
Arch unveils $500M, Amgen-allied bet on neuroscience's future
Neumora starts life with $500 million, a pact with Amgen, a pipeline of eight prospects and plans to create precision medicines for brain diseases.
Nick Paul Taylor
Oct 7, 2021 6:30am
BlackThorn bags $76M to push targeted treatments for brain disorders
Jun 13, 2019 8:30am
BIO urges more VC, R&D, starting with depression
Jan 19, 2018 11:04am
